Association between plasma fluorescent oxidation products and erectile dysfunction: A prospective study.

PubWeight™: 0.75^‹?›

🔗 View Article (PMC 4536733)

Published in BMC Urol on August 14, 2015

Authors

Shuman Yang¹, Edward Giovannucci²^,3, Bruce Bracken⁴, Shuk-Mei Ho⁵^,6, Tianying Wu⁷

Author Affiliations

1: Division of Epidemiology and Biostatistics, Department of Environmental Health, University of Cincinnati Medical Center, Kettering Complex, 3223 Eden Ave, Cincinnati, OH, USA, 45267-0056. ysm992511@sina.com.
2: Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, MA, USA. egiovann@hsph.harvard.edu.
3: The Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. egiovann@hsph.harvard.edu.
4: Department of Surgery, University of Cincinnati Medical Center, Cincinnati, OH, USA. brace.bracken@uc.edu.
5: Division of Environmental Genetics and Molecular Toxicology, Cincinnati, OH, USA. hosm@ucmail.uc.edu.
6: Center for Environmental Genetics, University of Cincinnati Medical Center, Cincinnati, OH, USA. hosm@ucmail.uc.edu.
7: Division of Epidemiology and Biostatistics, Department of Environmental Health, University of Cincinnati Medical Center, Kettering Complex, 3223 Eden Ave, Cincinnati, OH, USA, 45267-0056. tianying.wu@uc.edu.

Articles cited by this ↗

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol (1994) 10.03

Role of oxidative stress in atherosclerosis. Am J Cardiol (2003) 3.66

Nitric oxide: a physiologic mediator of penile erection. Science (1992) 3.39

Prevalence and risk factors for erectile dysfunction in the US. Am J Med (2007) 2.84

Plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies. Am J Epidemiol (2007) 1.68

Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants. J Urol (2005) 1.65

Oxidative stress and atherosclerosis. Pathophysiology (2006) 1.52

Prospective study of restless legs syndrome and risk of erectile dysfunction. Am J Epidemiol (2013) 1.47

Paraoxonase activity in patients with erectile dysfunction. Int J Impot Res (2007) 1.42

Plasma levels of nitrate and risk of prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev (2013) 1.42

Stability of measurements of biomarkers of oxidative stress in blood over 36 hours. Cancer Epidemiol Biomarkers Prev (2004) 1.14

Plasma fluorescent oxidation products: independent predictors of coronary heart disease in men. Am J Epidemiol (2007) 1.06

Role of oxidative stress in the pathophysiological mechanism of erectile dysfunction. J Androl (2005) 1.04

Risk factors for erectile dysfunction in a cohort of 108 477 Australian men. Med J Aust (2013) 0.95

The association of plasma fluorescent oxidation products and chronic kidney disease: a case-control study. Am J Nephrol (2012) 0.94

Fluorescent oxidation products and risk of coronary heart disease: a prospective study in women. J Am Heart Assoc (2013) 0.94

Oxygen free radicals and the penis. Expert Opin Pharmacother (2002) 0.92

Reactive oxygen species and erectile dysfunction: possible role of NADPH oxidase. Int J Impot Res (2006) 0.92

Plasma florescent oxidation products and breast cancer risk: repeated measures in the Nurses' Health Study. Breast Cancer Res Treat (2013) 0.89

Oxidative stress and antioxidant status in patients with erectile dysfunction. J Sex Med (2009) 0.86

Evaluation of serum oxidative and antioxidative status in patients with erectile dysfunction. Andrologia (2011) 0.78